Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Accuray Incorporated before investing.

In this article, we go over a few key elements for understanding Accuray Incorporated’s stock price such as:

• Accuray Incorporated’s current stock price and volume
• Why Accuray Incorporated’s stock price changed recently
• Upgrades and downgrades for ARAY from analysts
• ARAY’s stock price momentum as measured by its relative strength

About Accuray Incorporated (ARAY)

Before we jump into Accuray Incorporated’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Want to learn more about Accuray Incorporated’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Accuray Incorporated.

Accuray Incorporated’s Stock Price as of Market Close

As of November 26, 2025, 4:00 PM, CST, Accuray Incorporated’s stock price was $1.040.

Accuray Incorporated is up 2.97% from its previous closing price of $1.010.

During the last market session, Accuray Incorporated’s stock traded between $0.995 and $1.060. Currently, there are approximately 118.95 million shares outstanding for Accuray Incorporated.

Accuray Incorporated’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Accuray Incorporated Stock Price History

Accuray Incorporated’s (ARAY) price is currently down 26.24% so far this month.

During the month of November, Accuray Incorporated’s stock price has reached a high of $1.460 and a low of $0.914.

Over the last year, Accuray Incorporated has hit prices as high as $2.950 and as low as $0.914. Year to date, Accuray Incorporated’s stock is down 47.47%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Accuray Incorporated Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 26, 2025, there was 1 analyst who downgraded Accuray Incorporated’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Accuray Incorporated’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Accuray Incorporated’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Accuray Incorporated’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Accuray Incorporated (ARAY) by visiting AAII Stock Evaluator.

Relative Price Strength of Accuray Incorporated

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 26, 2025, Accuray Incorporated has a weighted four-quarter relative price strength of -20.60%, which translates to a Momentum Score of 9 and is considered to be Very Weak.

Want to learn more about how Accuray Incorporated is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Accuray Incorporated Stock Price: Bottom Line

As of November 26, 2025, Accuray Incorporated’s stock price is $1.040, which is up 2.97% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Accuray Incorporated stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.